Logo image of RDBX

REDBOX ENTERTAINMENT INC (RDBX) Stock Fundamental Analysis

NASDAQ:RDBX - US75724T1034 - Common Stock

1.65 USD
-1.85 (-52.86%)
Last: 8/10/2022, 8:09:16 PM
1.655 USD
+0.01 (+0.3%)
After Hours: 8/10/2022, 8:09:16 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RDBX. RDBX was compared to 75 industry peers in the Entertainment industry. Both the profitability and financial health of RDBX have multiple concerns. While showing a medium growth rate, RDBX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year RDBX has reported negative net income.
RDBX Yearly Net Income VS EBIT VS OCF VS FCFRDBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA -33.02%
ROE N/A
ROIC -68.8%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDBX Yearly ROA, ROE, ROICRDBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -1K -2K -3K -4K

1.3 Margins

Industry RankSector Rank
OM -56.07%
PM (TTM) -33.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDBX Yearly Profit, Operating, Gross MarginsRDBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 20 -20 -40

0

2. Health

2.1 Basic Checks

RDBX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RDBX has more shares outstanding
The debt/assets ratio for RDBX is higher compared to a year ago.
RDBX Yearly Shares OutstandingRDBX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M 40M
RDBX Yearly Total Debt VS Total AssetsRDBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -2.63, we must say that RDBX is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of -9.59 indicates that RDBX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -9.59
Debt/FCF N/A
Altman-Z -2.63
ROIC/WACC-8.31
WACC8.28%
RDBX Yearly LT Debt VS Equity VS FCFRDBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.44 indicates that RDBX may have some problems paying its short term obligations.
RDBX has a Quick Ratio of 0.44. This is a bad value and indicates that RDBX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
RDBX Yearly Current Assets VS Current LiabilitesRDBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

RDBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.09%.
The Revenue for RDBX has decreased by -47.17% in the past year. This is quite bad
Measured over the past years, RDBX shows a very negative growth in Revenue. The Revenue has been decreasing by -42.02% on average per year.
EPS 1Y (TTM)-131.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.44%
Revenue 1Y (TTM)-47.17%
Revenue growth 3Y-42.02%
Revenue growth 5YN/A
Sales Q2Q%-17.6%

3.2 Future

RDBX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.02% yearly.
RDBX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 52.49% yearly.
EPS Next Y54.42%
EPS Next 2Y39.52%
EPS Next 3Y38.39%
EPS Next 5Y43.02%
Revenue Next Year34.49%
Revenue Next 2Y51.76%
Revenue Next 3Y49.66%
Revenue Next 5Y52.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RDBX Yearly Revenue VS EstimatesRDBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
RDBX Yearly EPS VS EstimatesRDBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

RDBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RDBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDBX Price Earnings VS Forward Price EarningsRDBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.16
RDBX Per share dataRDBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as RDBX's earnings are expected to grow with 38.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.52%
EPS Next 3Y38.39%

0

5. Dividend

5.1 Amount

No dividends for RDBX!.
Industry RankSector Rank
Dividend Yield N/A

REDBOX ENTERTAINMENT INC

NASDAQ:RDBX (8/10/2022, 8:09:16 PM)

After market: 1.655 +0.01 (+0.3%)

1.65

-1.85 (-52.86%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13 2022-05-13/amc
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner Change0%
Ins Owners4.26%
Ins Owner Change0%
Market Cap22.58M
Analysts45
Price Target2.21 (33.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-0.24%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -4.16
EPS(TTM)-9.33
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS25.7
BVpS-2.3
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.02%
ROE N/A
ROCE N/A
ROIC -68.8%
ROICexc N/A
ROICexgc 441.92%
OM -56.07%
PM (TTM) -33.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity -9.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -2.63
F-Score2
WACC8.28%
ROIC/WACC-8.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.44%
EPS Next Y54.42%
EPS Next 2Y39.52%
EPS Next 3Y38.39%
EPS Next 5Y43.02%
Revenue 1Y (TTM)-47.17%
Revenue growth 3Y-42.02%
Revenue growth 5YN/A
Sales Q2Q%-17.6%
Revenue Next Year34.49%
Revenue Next 2Y51.76%
Revenue Next 3Y49.66%
Revenue Next 5Y52.49%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A